Cargando…
Ingenol mebutate in the treatment of actinic keratoses: clearance rate and adverse effects
BACKGROUND: Actinic keratoses are benign intraepithelial skin neoplasms that develop in photoexposed areas and can progress to invasive carcinoma. They are seen frequently in dermatological practice, occurring in 5.1% of consultations. Ingenol mebutate (IM) was recently approved in Brazil as a topic...
Autores principales: | Saraiva, Maria Isabel Ramos, Portocarrero, Larissa Karine Leite, Vieira, Marcella Amaral Horta Barbosa, Swiczar, Bethania Cabral Cavalli, Westin, Andrezza Telles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Dermatologia
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063094/ https://www.ncbi.nlm.nih.gov/pubmed/30066759 http://dx.doi.org/10.1590/abd1806-4841.20186982 |
Ejemplares similares
-
The Role of Ingenol Mebutate in the Treatment of Actinic Keratoses
por: Ali, Faisal R., et al.
Publicado: (2012) -
Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate
por: Emmert, Steffen, et al.
Publicado: (2016) -
Efficacy of Ingenol Mebutate in the Treatment of Actinic Keratoses: A Pre- and Posttreatment Dermoscopic Comparative Analysis
por: Carbotti, Mattia, et al.
Publicado: (2018) -
Bier’s spots with onset in childhood
por: Portocarrero, Larissa Karine Leite, et al.
Publicado: (2016) -
Improved patient satisfaction using ingenol mebutate gel 0.015% for the treatment of facial actinic keratoses: a prospective pilot study
por: Emilio, Joanna, et al.
Publicado: (2016)